BackMineralys Therapeutics Overview

Mineralys Therapeutics Total Assets

Mineralys Therapeutics's total assets is $670M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$667.85M
98.93% YoYΔ $332.13M vs prior year quarter

Peer trimmed avg / median

Loading

Mineralys Therapeutics Total Assets History

Loading

Mineralys Therapeutics vs. peers: Total Assets Comparison

Loading

Mineralys Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mineralys Therapeutics (MLYS) FAQ

As of the most recent data (June 2026), MLYS shows a total assets of $670M. That compares with $340M in the prior-year period — up 98.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLYS's total assets is now $670M (was $340M) — a 98.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Mineralys Therapeutics is outperforming or lagging.

Tracking MLYS's total assets over time shows whether Mineralys Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $670M That compares with $340M in the prior-year period — up 98.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Mineralys Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $670M) with ownership activity and broader fundamentals.